University of Texas Investment Management Company

University Of Texas/texas Am Investment Managment as of June 30, 2021

Portfolio Holdings for University Of Texas/texas Am Investment Managment

University Of Texas/texas Am Investment Managment holds 18 positions in its portfolio as reported in the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Taysha Gene Therapies (TSHA) 22.6 $30M 1.4M 21.20
Beam Therapeutics (BEAM) 22.2 $29M 224k 128.71
Elliott Opportunity Ii Corp 15.4 $20M 2.0M 10.01
Vanguard Total World Stock Etf Etfs (VT) 12.6 $16M 159k 103.61
Codiak Biosciences 12.0 $16M 847k 18.53
Immatics (IMTX) 6.2 $8.1M 697k 11.61
Texas Instruments Incorporated (TXN) 4.7 $6.2M 32k 192.31
Aeglea Biotherapeutics 1.4 $1.9M 270k 6.96
Soliton 1.3 $1.7M 75k 22.49
Plx Pharma 0.7 $865k 63k 13.80
Pioneer Natural Resources (PXD) 0.5 $594k 3.7k 162.47
Tff Pharmaceuticals 0.2 $212k 22k 9.61
Lexicon Pharmaceuticals (LXRX) 0.1 $164k 36k 4.59
Apollo Endosurgery 0.1 $126k 16k 8.08
Weyerhaeuser Company (WY) 0.0 $34k 1.0k 34.00
Apple (AAPL) 0.0 $27k 200.00 135.00
UnitedHealth (UNH) 0.0 $10k 25.00 400.00
Portland General Electric Company (POR) 0.0 $5.0k 118.00 42.37